Ketoconazole was administered to 12 patients with candidiasis. There were 5 cases of oral candidiasis, 2 of oral and esophageal candidiasis, 2 of candidemia, 1 of candidal meningitis and 2 of candiduria.
This agent was highly effective against superficial candidiasis, especially against oral candidiasis, the lesions being clinically cured within a few days of administration.
In the patients with candidemia, which had occurred as a complication due to an indwelling venous catheter, fever subsided and blood cultures were negative after the administration of ketoconazole. One patient died of acute renal failure following digitalis intoxication on the 11th day of administration and the post-mortem examination showed germ-tube forming
Candida and phagocyted mycelia in the pulmonary vascular lesions due to the underlying disease (malignant rheumatoid arthritis).
Candida circulating in the blood may localize in any organ where a locus minoris resistentiae due to an underlying disease is present and gives rise to local infections such as pneumonia. Early treatment is therefore important. In another case where candidemia was accompanied by candidal suppurative thrombophlebitis during prolonged intravenous therapy, excision of the affected vein cured the patient.
Candidal meningitis was cured by combined administration of ketoconazole and flucytosine. It is necessary to change the site where the catheter is inserted, since this disease occurs concurrently following techniques such as cerebrospinal fluids drainage. Ketoconazole has a low penetration into the cerebrospinal fluids; high-dose therapy or combined therapy using ketoconazole with amphotericin B and/or flucytosine should be considered.
Favorable results were obtained with ketoconazole treatment against candiduria, but additional studies are necessary. No severe side effects were observed. Our findings indicate that ketoconazole is potentially effective in candidiasis.
View full abstract